Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA Disculpen las molestias.
 

Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation

dc.contributor.authorRubio Langre, Sonia
dc.contributor.authorAguilar Sola, Soledad
dc.contributor.authorLorenzutti, Augusto Matías
dc.contributor.authorSan Andrés Larrea, Manuel Ignacio
dc.contributor.authorLucas Burneo, José Julio De
dc.contributor.authorLitterio, Nicolás J.
dc.date.accessioned2024-12-12T13:00:59Z
dc.date.available2024-12-12T13:00:59Z
dc.date.issued2018
dc.descriptionJUSTIFICACIÓN DE AUTORES All authors have read and approved the final manuscript. S. R. L.: Design, acquisition, analysis and interpretation of data. S. A. S.: Acquisition, analysis and interpretation of data. A. M. L.: Analysis, interpretation of data and drafting the manuscript. M. I. S. A.: Design and critical revision of the manuscript for important intellectual content. J. J. D. L.: Acquisition, analysis of data and critical revision of the manuscript for important intellectual content. N. J. L.: Design and critical revision of the manuscript for important intellectual content.
dc.description.abstractIn llama crias (tekes), Escherichia coli and Staphylococcus aureus are major pathogens, and marbofloxacin could be a suitable choice. The objectives of this study were (a) to evaluate the serum pharmacokinetics of marbofloxacin (5 mg/kg) after intravenous administration in tekes and simulate a multidose regimen; (b) to emulate pharmacokinetic profiles after single dose and steady-state conditions by Monte Carlo simulation (c) to determine the MIC of regional strains of Escherichia coli and Staphylococcus aureus; (d) to perform a PK/PD analysis by Monte Carlo simulation. Pharmacokinetics of marbofloxacin was evaluated in six animals at 3, 10, 24, 50, and 80 days after birth. Marbofloxacin were determined by HPLC. A steady-state multi-dose simulation was carried out, and concentration-time profiles were generated by Monte Carlo simulation. MIC of marbofloxacin against regional E. coli and S. aureus strains were also determined. Finally, a PK/PD analysis was conducted by Monte Carlo simulation. After pharmacokinetic analysis, clearance showed a trend to increase (0.14 and 0.18 L kg−1 hr−1), and AUC (36.74 and 15.21 μg hr−1 ml−1) and Vss (3.06 and 3.37 L/kg) trended to decrease at 3 and 80 days-old, respectively, showing accumulation ~50% in animals with 3 days. All strains tested of E. coli (MIC90 = 0.06 μg/ml) and S. aureus (MIC90 = 0.25 μg/ml) were susceptible to marbofloxacin. PK/PD analysis suggests that the therapeutic regimen of marbofloxacin could be effective for infections caused by E. coli strains in animals between 3 and 80 days, with a CFR for Cmax/MIC > 10 of 100% and for AUC24/MIC > 125 of 99.99%; and for infections produced by S. aureus in animals between 3 and 24 days old, with a CFR for Cmax/MIC > 10 of 93.08% and for AUC24/MIC > 60 of 97.01%, but a higher dose should be used in older animals, because PK/PD endpoints were not met.
dc.description.departmentSección Deptal. de Farmacología y Toxicología (Veterinaria)
dc.description.facultyFac. de Veterinaria
dc.description.refereedTRUE
dc.description.sponsorshipUniversidad Complutense de Madrid
dc.description.sponsorshipUniversidad Católica de Córdoba (Argentina)
dc.description.statuspub
dc.identifier.citationRubio-Langre S, Aguilar-Sola S, Lorenzutti AM, San Andrés MI, De Lucas JJ, Litterio NJ. Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation. J vet Pharmacol Therap. 2018; 41: 861–870. https://doi.org/10.1111/jvp.12698
dc.identifier.doi10.1111/jvp.12698
dc.identifier.essn1365-2885
dc.identifier.essn0140-7783
dc.identifier.officialurlhttps://doi.org/10.1111/JVP.12698
dc.identifier.pmid30020535
dc.identifier.urihttps://hdl.handle.net/20.500.14352/112530
dc.issue.number6
dc.journal.titleJournal of Veterinary Pharmacology and Therapeutics
dc.language.isoeng
dc.page.final870
dc.page.initial861
dc.publisherWiley
dc.rights.accessRightsrestricted access
dc.subject.cdu636.09:615
dc.subject.keywordLlamas
dc.subject.keywordMarbofloxacin
dc.subject.keywordMonte Carlo simulation
dc.subject.keywordPharmacodynamics
dc.subject.keywordPharmacokinetics
dc.subject.ucmFarmacología veterinaria
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco3109.08 Farmacología
dc.titlePharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number41
dspace.entity.typePublication
relation.isAuthorOfPublicatione7470fe4-3dc5-4906-9268-64fad1e71642
relation.isAuthorOfPublicationcac20145-bbd1-4b94-9c81-0349adc65fa4
relation.isAuthorOfPublication8da3734c-6aae-4b8d-b6d7-a32bc113d18a
relation.isAuthorOfPublication.latestForDiscoverye7470fe4-3dc5-4906-9268-64fad1e71642

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PK PD monte carlo.pdf
Size:
636.52 KB
Format:
Adobe Portable Document Format

Collections